ClinicalTrials HQ

COVID-19 Antibody Responses In Cystic Fibrosis

COVID-19 Antibody Responses In Cystic Fibrosis

Active, not recruiting · NCT04863573 · Registry updated 2026-08-28
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
COVID-19 Antibody Responses In Cystic FibrosisCOVID-19, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Coronaviridae Infections, Digestive System Diseases, Infant, Newborn, Diseases, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, cystic fibrosis, hereditary disease, lung disorder, pancreas disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumoniaActive, not recruitingNot stated2026-08-28NCT04863573

2 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Cystic Fibrosis Foundation42
Queen's University, Belfast29

11 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Birmingham Women'S and Children'S Nhs Foundation TrustBirminghamUnited Kingdom2
Cardiff & Vale University LhbCardiffUnited Kingdom1
Cardiff & Vale University LhbCardiffUnited Kingdom1
King's College Hospital NHS Foundation TrustLondonUnited Kingdom7
Leeds Teaching Hospitals Nhs TrustLeedsUnited Kingdom1
NHS Greater Glasgow and ClydeGlasgowUnited Kingdom3
Nottingham University Hospitals Nhs TrustNottinghamUnited Kingdom2
Queens University BelfastBelfastUnited Kingdom1
Royal Brompton & Harefield Nhs Foundation TrustLondonUnited Kingdom1
University Hospital Southampton Nhs Foundation TrustSouthamptonUnited Kingdom1
University Hospitals Birmingham Nhs Foundation TrustBirminghamUnited Kingdom1